Global Sepsis Diagnostics Market 2017-2021

  • ID: 4416730
  • Report
  • Region: Global
  • 86 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abionic
  • Beckman Coulter
  • Cepheid
  • Fujirebio Europe
  • Merck
  • Radiometer
  • MORE
About Sepsis Diagnostics

Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock, which is regarded as a medical emergency. Population with weak immune system, which include children, older adults, and people with chronic diseases such as cancer, AIDS, diabetes, are prone to sepsis.
Sepsis occurs mainly due to bacterial, viral, and fungal infections. Gram-negative bacilli such as E. coli, P. aeruginosa, E. corrodens, and Haemophilus influenzae (which occurs mainly in neonates) are the main agents that cause infection, leading to sepsis. Other bacteria which causes sepsis are S. aureus, Streptococcus species, Enterococcus species, and Neisseria species.

The analysts forecast the global sepsis diagnostics market to grow at a CAGR of 6.74% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global sepsis diagnostics market for 2017-2021. To calculate the market size, the report considers the sales, volume and value of global sepsis diagnostics segment.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Sepsis Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • bioMérieux
  • T2 Biosystems
Other prominent vendors
  • Alere
  • Abionic
  • AdvanDx
  • Aethlon Medical
  • AusDiagnostics
  • Beckman Coulter
  • Beckton Dickinson
  • Momentum Bioscience
  • Bio-Rad Laboratories
  • Bruker
  • Cepheid
  • Curetis
  • CytoSorbents
  • Fast Track Diagnostics
  • F. Hoffmann-La Roche
  • Fujirebio Europe
  • Hansa Medical
  • Hain Lifescience
  • Immunexpress
  • Inflammatix
  • Merck
  • miacom diagnostics
  • Mitsubishi Chemical Europe
  • Nanomix
  • QIAGEN
  • Radiometer
  • Response Biomedical
  • Sepset Biosciences
  • Siemens Healthineers
  • TCS Biosciences
  • Thermo Fisher Scientific
Market drivers
  • Rising prevalence of hospital acquired infection (HAIs) globally
  • For a full, detailed list, view the full report
Market challenges
  • High cost of sepsis treatment
  • For a full, detailed list, view the full report
Market trends
  • Increasing use of biomarkers for sepsis
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abionic
  • Beckman Coulter
  • Cepheid
  • Fujirebio Europe
  • Merck
  • Radiometer
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research methodology

PART 04: Introduction
  • Market outline
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by technology
  • Market overview
  • Immunoassay testing
  • POCT
  • Molecular testing
PART 07: Market segmentation by end-user
  • Market overview
  • Hospital and clinics
  • Diagnostic laboratories
PART 08: Geographical segmentation
  • Sepsis diagnostics market in Americas
  • Sepsis diagnostics market in EMEA
  • Sepsis diagnostics market in APAC
PART 09: Decision framework

PART 10: Drivers and challenges
  • Market drivers
  • Market challenges
PART 11: Market trends
  • Development of novel products
  • Increasing use of biomarkers for sepsis
  • Increasing online campaigns for sepsis awareness
PART 12: Vendor landscape
  • Competitive landscape
PART 13: Key vendors
  • bioMérieux
  • T2 Biosystems
  • Key companies to watch
  • Other prominent vendors
  • List of abbreviations
PART 14: Appendix

List of Exhibits
Exhibit 01: Stages of sepsis
Exhibit 02: Products offered for severity of sepsis
Exhibit 03: Market overview: Global sepsis diagnostics market 2016-2021
Exhibit 04: Global sepsis diagnostics market 2016-2021 ($ millions)
Exhibit 05: Reimbursement for sepsis in the US
Exhibit 06: Five forces analysis
Exhibit 07: Market overview of sepsis diagnostics by technology 2016
Exhibit 08: Global sepsis diagnostics market by immunoassay testing 2016-2021 ($ millions)
Exhibit 09: Global sepsis diagnostics market by POCT 2016-2021 ($ millions)
Exhibit 10: Global sepsis diagnostics market by molecular testing 2016-2021 ($ millions)
Exhibit 11: Strategic analysis: Global sepsis diagnostics market by end-users 2016
Exhibit 12: Buying criteria for global sepsis diagnostics market by end user 2016
Exhibit 13: Global sepsis diagnostics market by geography in 2016 and 2021 ($ millions)
Exhibit 14: Market overview: Sepsis diagnostics market in Americas 2016-2021
Exhibit 15: Sepsis diagnostics market in Americas 2016-2021 ($ millions)
Exhibit 16: Market overview: Sepsis diagnostics market in EMEA 2016-2021
Exhibit 17: Sepsis diagnostics market in EMEA 2016-2021 ($ millions)
Exhibit 18: Market overview: Sepsis diagnostics market in APAC 2016-2021
Exhibit 19: Sepsis diagnostics market in APAC 2016-2021 ($ millions)
Exhibit 20: Market analysis: Sepsis-related to HAI
Exhibit 21: Ongoing clinical trials by NHS in the UK
Exhibit 22: Competitive structure analysis of global sepsis diagnostics market 2016
Exhibit 23: Market penetration of various global sepsis diagnostics market providers 2016
Exhibit 24: Strategic success factors of companies in global sepsis diagnostics market 2016
Exhibit 25: bioMérieux: Key highlights
Exhibit 26: bioMérieux: Strength assessment
Exhibit 27: bioMérieux: Strategy assessment
Exhibit 28: bioMérieux: Opportunity assessment
Exhibit 29: T2 Biosystems: Key highlights
Exhibit 30: T2 Biosystems: Strength assessment
Exhibit 31: T2 Biosystems: Strategy assessment
Exhibit 32: T2 Biosystems: Opportunity assessment
Exhibit 33: Abbott: Company assessment
Exhibit 34: Nanosphere: Company assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abionic
  • Beckman Coulter
  • Cepheid
  • Fujirebio Europe
  • Merck
  • Radiometer
  • MORE
New Report Released: – Global Sepsis Diagnostics Market 2017-2021

The author of the report recognizes the following companies as the key players in the global sepsis diagnostics market: bioMérieux and T2 Biosystems

Other Prominent Vendors in the market are: Alere, Abionic, AdvanDx, Aethlon Medical, AusDiagnostics, Beckman Coulter, Beckton Dickinson, Momentum Bioscience, Bio-Rad Laboratories, Bruker, Cepheid, Curetis, CytoSorbents, Fast Track Diagnostics, F. Hoffmann-La Roche, Fujirebio Europe, Hansa Medical, Hain Lifescience, Immunexpress, Inflammatix, Merck, miacom diagnostics, Mitsubishi Chemical Europe, Nanōmix, QIAGEN, Radiometer, Response Biomedical, Sepset Biosciences, Siemens Healthineers, TCS Biosciences, and Thermo Fisher Scientific.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is Increasing use of biomarkers for sepsis. The increased preference for biomarkers offers homogeneity of risk or disease status of the patient within limited time and provides precision diagnosis will increase its adoption rate. Biomarkers are used as diagnostic tools for the diagnosis of a disease or abnormal conditions of sepsis, including severe sepsis. The accuracy and timely detection of sepsis are regarded as the significant challenges. Therefore, the health providers rely on nonspecific clinical and laboratory signs.”

According to the report, one of the major drivers for this market is Rising prevalence of hospital acquired infection (HAIs) globally. Increasing cases of HAIs in the population is the leading cause of sepsis. HAI is also known as the nosocomial infection, which may affect the population during hospitalization or after the patient is discharged from the hospital. The presence of immunocompromised patients in hospitals, transmission of the pathogen between the staff and the patient, and the presence of microorganisms and contaminated particles in the hospital environment are the major factors that result in HAIs. The number of cases for HAIs is on the rise across the world, leading to septicemia. This drives the demand for sepsis diagnostics worldwide.

Further, the report states that one of the major factors hindering the growth of this market is High cost of sepsis treatment. The high cost of sepsis treatment is regarded as one of the market constraints, which affects the growth of the sepsis diagnostics market. Therefore, the high price of procedures decreases the adoption rate of this product, especially in the reference laboratories and small clinics where the budget allocated is very less. However, the cost-efficient treatment is likely to increase the adoption rate during the forecast period.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • bioMérieux
  • T2 Biosystems
  • Alere
  • Abionic
  • AdvanDx
  • Aethlon Medical
  • AusDiagnostics
  • Beckman Coulter
  • Beckton Dickinson
  • Momentum Bioscience
  • Bio-Rad Laboratories
  • Bruker
  • Cepheid
  • Curetis
  • CytoSorbents
  • Fast Track Diagnostics
  • F. Hoffmann-La Roche
  • Fujirebio Europe
  • Hansa Medical
  • Hain Lifescience
  • Immunexpress
  • Inflammatix
  • Merck
  • miacom diagnostics
  • Mitsubishi Chemical Europe
  • Nanomix
  • QIAGEN
  • Radiometer
  • Response Biomedical
  • Sepset Biosciences
  • Siemens Healthineers
  • TCS Biosciences
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll